Close
Enter your
text here

Obesity

What Pediatric Endocrinologists Need to Know About Diabetes in the Age of GLP-1s
 What Pediatric Endocrinologists Need to Know About Diabetes in the Age of GLP-1s 1024 683 Erin Gregory
By: Erin Gregory

GLP-1 receptor agonists such as Ozempic (semaglutide) offer new opportunities for managing pediatric diabetes and obesity. These medications target insulin resistance and related comorbidities, but their use raises questions about safety, access and ethical considerations. In the following interview, Leena Mamilly, MD, and Rohan K. Henry, MD, pediatric endocrinology experts at Nationwide Children’s Hospital, explore…

Treating Obesity With GLP-1s — Finding the Way Forward
 Treating Obesity With GLP-1s — Finding the Way Forward 150 150 Abbie Miller
By: Abbie Miller

Using lessons learned from medicating mental and behavioral health conditions, Stephen Cook, MD, offers suggestions about how medications approved for adolescents with obesity should become part of care.   For most of the time in Western medicine, people have treated obesity like a choice — not a disease. Like other conditions now understood to be…

Patient Perspective: Living With Weight-Based Stigma
 Patient Perspective: Living With Weight-Based Stigma 1024 376 Alaina Doklovic
By: Alaina Doklovic

In 2019, 15-year-old Paige watched her father die from a disease that was consistently ignored, and his symptoms repeatedly blamed on his weight. He had stage 4 cancer by the time he was properly diagnosed. Shortly after his death, her mother had a 40-pound cyst removed, a surgery that she and other doctors believe could…

Weight-Based Stigma and Its Impact on Children With Obesity
 Weight-Based Stigma and Its Impact on Children With Obesity 1024 376 Alaina Doklovic
By: Alaina Doklovic

More children in the United States live with obesity than any other chronic condition. The obesity rate among U.S. children and teens has more than tripled since 1980, according to the Centers for Disease Control and Prevention (CDC). Although there are numerous efforts underway to help children and adults reach and maintain a healthy weight,…

How Do Treatments for Adolescent Obesity Compare?
 How Do Treatments for Adolescent Obesity Compare? 1024 682 Pam Georgiana
By: Pam Georgiana

A recent review of the literature highlights current treatment strategies for adolescent obesity. According to the American Academy of Pediatrics (AAP), obesity and severe obesity are chronic health conditions with increasing incidence in adolescents, putting them at risk for associated comorbidities. Obesity affects approximately 21% of adolescents (12 to 18 years of age) in the…

Associations Between Blood-Based and Biochemical Markers of Inflammation and Body Mass
 Associations Between Blood-Based and Biochemical Markers of Inflammation and Body Mass 1024 575 Mary Bates, PhD
By: Mary Bates, PhD

Blood-based markers of inflammation increased with increasing body mass in healthy adolescents. The chronic inflammatory disease atherosclerosis has its origins in childhood and adolescence; however, there are currently no simple methods to easily identify at-risk adolescents.  In a new study, researchers at Nationwide Children’s Hospital explored the relationships between blood-based and biochemical markers of inflammation…

Pediatric Obesity Can Be Treated Safely and Effectively
 Pediatric Obesity Can Be Treated Safely and Effectively 1024 575 Abbie Miller
By: Abbie Miller

New guidelines from the American Academy of Pediatrics emphasize evidence for safe, effective treatment of pediatric obesity for long-term benefit of children and adolescents.   More than 14.4 million U.S. children and adolescents have obesity, making it one of the most common chronic conditions facing American youth and families. Obesity is a chronic disease associated…